Westchester Capital Management (New York)’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

Westchester Capital Management (New York)’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-839,833	Closed	-$8.68M	–	520
2022 Q4	$8.68M	Buy	839,833 +485,328	+137%	+$4.97M	0.24%	99
2022 Q3	$3.6M	Buy	+354,505	New	+$3.58M	0.1%	210

Westchester Capital Management (New York)'s THAC Position: Q1 2023 in Review

Westchester Capital Management (New York) sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 839,833 shares — an estimated $8.68M sold.

Westchester Capital Management (New York) first reported a position in THAC in Q3 2022 and held it in 2 quarters. The position peaked at $8.68M in Q4 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

Westchester Capital Management (New York) reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
Westchester Capital Management (New York) sold 839,833 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $8.68M.
Westchester Capital Management (New York) first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q3 2022 and held it in 2 quarters.
Westchester Capital Management (New York)'s Thrive Acquisition Corporation Class A ordinary shares position peaked at $8.68M in Q4 2022.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on Westchester Capital Management (New York)'s 13F filing for Q1 2023, filed 15 May 2023.